glp 1 agonist anti inflammatory Pro- and anti-inflammatory properties of GLP-1 receptor agonists. APC, GLP-1 receptor agonists as promising
Description
Health effects of overweight and obesity in 195 countries over 25 years
42) In SUSTAIN-6, patients treated with semaglutide had a lower risk of developing or worsening nephropathy, but a higher risk of complications from diabetic retinopathy than those receiving placebo (40)
doi: 10.1111/dom.14174
The massive size and heterogeneity of the diabetes and obesity patient populations offer ample opportunity for a range of products to simultaneously succeed
Methods Literature was searched and perspectives from 10 healthcare professionals with experience in switching patients with T2D to OW semaglutide from another GLP1RA were collated
Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide
